Edmund A. Gehan, PhD, Oral History Interview, March 28, 2003

Edmund A. Gehan, PhD, Oral History Interview, March 28, 2003

Download Full Interview Transcript (492 KB)

Download Navigation Materials & Table of Contents (22 KB)

Loading...

Media is loading
 

Description

Major Topics Covered:

  • Educational background and path to becoming a biostatistician
  • Early career at the National Institute of Health
  • Fellowship at Birkberck in London with Sir David R. Cox
  • Early collaborations with Drs. Frei and Freireich at the NIH
  • Administrative dynamics at MD Anderson

Identifier

GehanE_01_20030328

Publication Date

3-28-2003

Publisher

The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center

City

Houston, Texas

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Topics Covered

University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute

Disciplines

History of Science, Technology, and Medicine | Oncology | Oral History

About the Interview

Biographical Note:

Edmund A. Gehan, Ph.D., was born in Brooklyn, New York in 1929. He attended Manhattan College where he received his Bachelor of Science degree in Mathematics. Gehan was awarded his Doctorate in Applied Statistics from the University of North Carolina in Chapel Hill/ He taught Applied Statistics from 1955 to 1957. He worked for the National Institute of Health (NIH) in 1958 and was the head of the Biometrics Section of the Cancer Chemotherapy National Service Center in 1959. He was a member of the National Cancer Institute (NCI).

Gehan’s work in Biostatistics brought him to Houston as a professor at the University of Texas M. D. Anderson Cancer Center in 1967; the institution was a member of the Southwest Oncology Group at that time. Prior to his appointment at M. D. Anderson, he collaborated with Drs. Emil Frei III and Emil J. Freireich cancer research. Gehan has coauthored numerous articles that influenced the development of cancer research with the use of data analysis in clinical trials. Two of which include the 1965 Biometika journal article “A Generalized Wilcoxon test for Comparing Arbitrarily Singly-Censored Samples” and the 1974 New England Medical Journal article “Non-randomized Controls in Cancer Clinical Trials.

Since 1994, Gehan is a Professor Emeritus of Biostatistics at Georgetown University Medical Center.

Selected Bibliography:

Gehan, E. A. (1961, April). The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. St. Louis: Journal of Chronic Diseases 13(4). 346-353.

Gehan, E. A. (1965). A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52(1 and 2). 203-223.

Gehan E. A., and Freireich E. J. (1981, December). Cancer clinical trials: A rational basis for use of historical controls. Seminars in Oncology, 8(4). 430-436

Gehan, E. A., and Freireich E. J. (1974, January 24). Non-randomized controls in cancer clinical trials. New England Journal of Medicine 290(4). 198-203.

Gehan, E. A., and Schneiderman, M. A. (1990). Historical and methodological developments in clinical trials at the National Cancer Institute. Statistics in Medicine 9. 871-880.

Gehan, E. A. (nd). How to find the cure for cancer. Journal of irreproducible results 35(4).

Conditions Governing Access

Open

Edmund A. Gehan, PhD, Oral History Interview, March 28, 2003

Share

COinS